Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort

医学 痹症科 耐火材料(行星科学) 队列 跨国公司 内科学 亚太地区 家庭医学 物理疗法 政治学 业务 天体生物学 物理 国际贸易 法学
作者
Rangi Kandane‐Rathnayake,Worawit Louthrenoo,Chak Sing Lau,Laniyati Hamijoyo,Jiacai Cho,Aisha Lateef,Shue‐Fen Luo,Yeong‐Jian Jan Wu,Sandra Navarra,Leonid D. Zamora,Zhanguo Li,Yi‐Hsing Chen,Shereen Oon,Madelynn Tsu-Li Chan,Sargunan Sockalingam,Yanjie Hao,Zhuoli Zhang,Sang‐Cheol Bae,Jun Kikuchi,Tsutomu Takeuchi
出处
期刊:Arthritis Research & Therapy [BioMed Central]
卷期号:27 (1): 155-155 被引量:5
标识
DOI:10.1186/s13075-025-03622-8
摘要

BACKGROUND: Emerging therapies have the potential to be used in patients with severe refractory systemic lupus erythematosus (srSLE), but no agreed definition of srSLE exists. We evaluated a pilot srSLE definition to assess whether a set of disease activity and treatment thresholds could identify patients with poor outcomes. METHODS: Data from a 13-country longitudinal SLE cohort, collected prospectively between 2013 and 2020 were analysed. srSLE was defined if a patient was in high disease activity (SLEDAI-2K ≥ 10) despite combination use of at least glucocorticoids (GC) and immunosuppressants (IS) at both the index and preceding visit. Synchronised to the index srSLE visit, we assessed disease activity, medication use and treat-to-target (T2T) endpoint attainment over 12 months (m). RESULTS: Of 3,744 patients studied, 578 (14%) had srSLE, in 1,810 visits. The median [IQR] SLEDAI-2K at the srSLE index visit was 12 [10, 14], which decreased to 6 [4, 10] at 6m and 12m. Most patients remained on combination anti-malarial, GC, and IS at all follow-up time points. The median [IQR] GC dose at the index visit was 10 [5, 20] mg/day; this reduced to 8 mg [5.0, 12.9] at 6m and 5 mg [5.0, 10.0] at 12m. Less than a quarter of patients attained LLDAS and only 1% attained GC-free remission over 12 months. CONCLUSIONS: A draft definition of srSLE was clearly associated with poor outcomes. Work to evaluate multiple thresholds with which to define srSLE, and their outcomes, is warranted.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YikY完成签到 ,获得积分10
刚刚
樱满集发布了新的文献求助10
刚刚
赵兵发布了新的文献求助10
1秒前
1秒前
马秀玲发布了新的文献求助10
2秒前
gwd发布了新的文献求助10
3秒前
4秒前
4秒前
Tan完成签到,获得积分10
4秒前
壮观的戒指完成签到,获得积分10
4秒前
大个的应助被Hiihaa采纳,获得10
4秒前
4秒前
4秒前
甜心超人完成签到,获得积分10
5秒前
5秒前
5秒前
Zn1发布了新的文献求助30
6秒前
苗雅宁完成签到,获得积分10
6秒前
诚心的琦发布了新的文献求助10
7秒前
神勇秋蝶完成签到,获得积分20
7秒前
落后裙子完成签到 ,获得积分10
7秒前
zd完成签到,获得积分10
7秒前
蛋黄流心包完成签到,获得积分10
8秒前
你好发布了新的文献求助10
9秒前
可爱的函函的应助被xixi采纳,获得10
10秒前
hhh发布了新的文献求助10
10秒前
传奇3的应助被赵兵采纳,获得10
10秒前
ZRT完成签到,获得积分10
10秒前
zd发布了新的文献求助10
11秒前
gwd完成签到,获得积分10
11秒前
元气马完成签到,获得积分10
13秒前
13秒前
Maestro_S的应助被ll采纳,获得20
15秒前
充电宝的应助被lmy采纳,获得10
16秒前
Nm完成签到,获得积分10
16秒前
zjy发布了新的文献求助10
16秒前
18秒前
动听衬衫发布了新的文献求助10
19秒前
大胆的姝完成签到,获得积分10
19秒前
77完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239